PineBridge Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$1.14K 747
2022
Q4
$1.14K Hold
100
﹤0.01% 724
2022
Q3
$2K Hold
100
﹤0.01% 717
2022
Q2
$2K Hold
100
﹤0.01% 717
2022
Q1
$4K Sell
100
-600
-86% -$23.4K ﹤0.01% 698
2021
Q4
$32K Buy
+700
New +$36.5K ﹤0.01% 744

Other funds holding CDNA

PineBridge Investments's CDNA Position: Q1 2023 in Review

PineBridge Investments sold out of CareDx (CDNA) in Q1 2023, closing a stake of 100 shares — an estimated $1.14K sold.

PineBridge Investments first reported a position in CDNA in Q4 2021 and held it in 5 quarters. The position peaked at $32K in Q4 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • PineBridge Investments reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • PineBridge Investments sold 100 CareDx shares in Q1 2023, an estimated $1.14K.
  • PineBridge Investments first reported a position in CareDx in Q4 2021 and held it in 5 quarters.
  • PineBridge Investments's CareDx position peaked at $32K in Q4 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on PineBridge Investments's 13F filing for Q1 2023, filed 12 May 2023.